Navigation Links
Recovery Act funds expand studies of stem cell biology
Date:10/28/2009

The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells, abbreviated iPS, are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

In theory, iPS cells could generate any type of cell and be used to treat diseases. But to realize this potential, scientists need a much better understanding of iPS cells' fundamental properties and how to efficiently derive cells that are safe for therapeutic uses.

To speed iPS research, NIGMS has awarded one-year grant supplements to 22 scientists at 16 institutions in 12 states and the District of Columbia. The investigators already have strong records of accomplishment in a range of research areas and will study iPS cells in varied biological systems.

"Stem cell biology is poised for rapid advances, and we expect our Recovery Act investment to have a catalytic effect. The new awards will contribute to the field's progress by enhancing the utility of iPS cells as tools for research, for testing the effects of drugs on human tissues and ultimately for patient-specific treatments," said NIGMS Director Jeremy M. Berg, Ph.D.

The Recovery Act funding will allow the scientists to address such important questions as:

  • How does reprogramming work?
  • What factors are necessary to create iPS cells efficiently and safely?
  • What drives iPS cells toward a desired cell type that can be used to regenerate or repair damaged tissues in a patient?
  • Do iPS cells differ from embryonic and adult stem cells, and if so, how?

The investigators receiving supplements are:

  • Bruce Beutler, Scripps Research Institute, La Jolla, Calif.
  • C. Anthony Blau, University of Washington, Seattle
  • Richard Cerione, Cornell University
    '/>"/>

Contact: Ann Dieffenbach
dieffena@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Survey finds elevated rates of new asthma among WTC rescue and recovery workers
2. New study shows greenback cutthroat trout involved in recovery effort misidentified
3. Recovery from acid rain much slower than expected
4. Diet and lifestyle critical to recovery, says study
5. Ozone hole recovery may reshape southern hemisphere climate change
6. Recovery efforts not enough for critically endangered Asian vulture
7. Diversity of plant-eating fishes may be key to recovery of coral reefs
8. Endangered sawfish focus of national collection and recovery efforts
9. Flowering plants speed post-surgery recovery
10. Long-term recovery of reefs from bleaching requires local action to increase resilience
11. Basic research critical to Americas economic recovery
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Recovery Act funds expand studies of stem cell biology
(Date:12/10/2014)... 2014 CIE San Diego has launched an ... connective tissue that enhances care coordination among social service ... client-level information; earned a second $1 million grant from ... seniors aging in community and; will be recognized as ... th 4-6p. CIE San Diego today ...
(Date:12/5/2014)... , Dec. 4, 2014 Increased emphasis ... investments in new testing and inspection technologies. The ... rise to a range of innovative test solutions. ... of Generation Y, which is generally more inclined ... result, product development strategies of test equipment vendors ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
Breaking Biology News(10 mins):Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Center will use IBM technologies to advance research into ... most life-threatening diseases, including cancer. The Center's research will ... biologists, Dr. Jeffrey Skolnick, the Georgia Research Alliance Eminent ... million in grants from the State of Georgia, the ...
... in the cruise industry, including cruise lines, local ... society organizations - are taking proactive measures to ... preserving cruise destinations, according to a new report ... Cruise Destinations issued by Conservation International's (CI) Center ...
... the threats that farmed Atlantic salmon escapees constitute ... are concerned about farmed salmon yet heritable changes ... genetic level are largely unknown. , In new ... have found scientific evidence that farmed salmon have ...
Cached Biology News:Georgia Tech accelerates drug discovery with new IBM supercomputing cluster 2Georgia Tech accelerates drug discovery with new IBM supercomputing cluster 3Georgia Tech accelerates drug discovery with new IBM supercomputing cluster 4Report finds cruise industry is protecting the precious places it visits 2Report finds cruise industry is protecting the precious places it visits 3Report finds cruise industry is protecting the precious places it visits 4
(Date:12/17/2014)... CA (PRWEB) December 17, 2014 ... today that it has entered into a technology ... Company (ADM) to apply DNA2.0’s proprietary protein engineering ... engineering process. , “We are extremely excited that ... engineering platform. This proprietary bioengineering technology has ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... NEW YORK , Dec. 15, 2014  GlassesOff ... Yuval Bar-Gil as an independent director of ... was founder of AeroScout and served as its CEO ... Decker in 2012, a $240 million transaction. Recognized as ... under Mr. Bar-Gil,s leadership, AeroScout provided Wi-Fi -based RFID ...
(Date:12/13/2014)... Maryland (PRWEB) December 12, 2014 Clarassance, ... today announced its new name: Therabron Therapeutics , ... therapy and bronchioles (a type of structure in the ... the company’s mission to develop novel protein therapeutics for ... of directors decided to change the name to mark ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... and ST. LOUIS, June 27, 2011 Verenium Corporation ... company focused on the development and commercialization of high-performance ... animal and human nutrition and health products, today announced ... suite of new enzyme products from Verenium,s late-stage product ...
... and LONDON, June 26, 2011 The pharmaceutical industry spent less ... last three years, according to data released today from the ... a Thomson Reuters business. Key highlights from the ... 21 new molecular entities (NMEs) were launched on the global market ...
... 2011 Selexis SA is a Swiss-based ... engineering of high yield and stable mammalian cell lines ... announced today it will be showcasing the new Selexis ... free SURE variant Screening at the 2011 BIO ...
Cached Biology Technology:Verenium and Novus International Inc. Announce Agreement to Develop and Commercialize Animal Nutrition Enzymes 2Verenium and Novus International Inc. Announce Agreement to Develop and Commercialize Animal Nutrition Enzymes 3Verenium and Novus International Inc. Announce Agreement to Develop and Commercialize Animal Nutrition Enzymes 4Verenium and Novus International Inc. Announce Agreement to Develop and Commercialize Animal Nutrition Enzymes 5Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International 2Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International 3Selexis SA to Give Away Euro 25,000 SUREvariant Screening Service Project at BIO 2011 2Selexis SA to Give Away Euro 25,000 SUREvariant Screening Service Project at BIO 2011 3
Rabbit polyclonal to FOXJ2 ( Abpromise for all tested applications). entrezGeneID: 55810 SwissProtID: Q9P0K8...
PI/RNase Staining Buffer Solution , 100 ml Consult technical datasheet for details....
Goat polyclonal to HSPC150 ( Abpromise for all tested applications). entrezGeneID: 29089...
Macrophage-stimulating protein receptor...
Biology Products: